1. Home
  2. ARWR vs HUT Comparison

ARWR vs HUT Comparison

Compare ARWR & HUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • HUT
  • Stock Information
  • Founded
  • ARWR 2003
  • HUT 2011
  • Country
  • ARWR United States
  • HUT United States
  • Employees
  • ARWR N/A
  • HUT N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • HUT Finance: Consumer Services
  • Sector
  • ARWR Health Care
  • HUT Finance
  • Exchange
  • ARWR Nasdaq
  • HUT Nasdaq
  • Market Cap
  • ARWR 1.8B
  • HUT 1.6B
  • IPO Year
  • ARWR 1993
  • HUT N/A
  • Fundamental
  • Price
  • ARWR $15.32
  • HUT $16.70
  • Analyst Decision
  • ARWR Buy
  • HUT Strong Buy
  • Analyst Count
  • ARWR 8
  • HUT 14
  • Target Price
  • ARWR $43.71
  • HUT $26.64
  • AVG Volume (30 Days)
  • ARWR 1.5M
  • HUT 6.3M
  • Earning Date
  • ARWR 08-07-2025
  • HUT 08-12-2025
  • Dividend Yield
  • ARWR N/A
  • HUT N/A
  • EPS Growth
  • ARWR N/A
  • HUT N/A
  • EPS
  • ARWR N/A
  • HUT N/A
  • Revenue
  • ARWR $545,209,000.00
  • HUT $132,459,000.00
  • Revenue This Year
  • ARWR $21,924.50
  • HUT $74.79
  • Revenue Next Year
  • ARWR N/A
  • HUT $116.78
  • P/E Ratio
  • ARWR N/A
  • HUT N/A
  • Revenue Growth
  • ARWR 1436.97
  • HUT 0.24
  • 52 Week Low
  • ARWR $9.57
  • HUT $8.73
  • 52 Week High
  • ARWR $30.41
  • HUT $31.95
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 46.47
  • HUT 50.50
  • Support Level
  • ARWR $15.19
  • HUT $17.35
  • Resistance Level
  • ARWR $16.06
  • HUT $18.60
  • Average True Range (ATR)
  • ARWR 0.68
  • HUT 1.07
  • MACD
  • ARWR -0.23
  • HUT -0.19
  • Stochastic Oscillator
  • ARWR 15.23
  • HUT 39.39

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About HUT Hut 8 Corp.

Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.

Share on Social Networks: